Lignospan

Epinephrine Bitartrate and Lidocaine Hydrochloride, the active ingredients in Lignospan, are a local anesthetic presented as a dental formulation for intra‑oral use. They provide rapid onset anesthesia, vasoconstriction to limit bleeding, and prolonged pain control during dental procedures.

GNH USA supplies Lignospan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lignospan is used in dentistry to achieve local anesthesia and hemostasis. - Dental anesthesia: produces profound numbness of the targeted oral tissues for routine extractions and restorations. - Pain control during dental procedures: reduces procedural discomfort and improves patient tolerance. - Minor oral surgery: facilitates incision, tissue manipulation, and suturing with minimal bleeding. - Periodontal therapy: enhances comfort during scaling, root planing, and other periodontal interventions.

Adverse reactions may occur with any local anesthetic containing epinephrine.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Local swelling or bruising: transient tissue edema. - Taste alteration: temporary metallic or bitter sensation. - Headache: mild to moderate intensity. - Dizziness or light‑headedness: usually resolves quickly. - Nausea: occasional mild upset stomach.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or anaphylaxis requiring immediate medical attention. - Cardiovascular events: hypertension, tachycardia, or arrhythmias. - Seizures: rare central nervous system excitation. - Prolonged numbness: lasting beyond the expected duration. - Tissue necrosis: due to excessive vasoconstriction. - Methemoglobinemia: very rare hemoglobin oxidation disorder.

Before using Lignospan, consider patient‑specific safety factors. - Allergy assessment: confirm no known hypersensitivity to lidocaine, epinephrine, or related compounds. - Cardiovascular disease: use with caution in patients with ischemic heart disease, arrhythmias, or uncontrolled hypertension. - Thyroid disorders: avoid in patients with hyperthyroidism or pheochromocytoma. - Drug interactions: review concomitant medications that may potentiate epinephrine effects. - Dosage limits: adhere to recommended maximum lidocaine dose for dental procedures. - Store at room temperature: keep in original container, protect from moisture and direct light.

Lignospan may interact with several systemic agents.

Major Interactions (Avoid): - Non‑selective beta‑blockers: can enhance epinephrine‑induced hypertension and tachycardia. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis when combined with epinephrine. - Tricyclic antidepressants: may potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs (e.g., ACE inhibitors, calcium channel blockers): may blunt desired vasoconstriction, requiring dose adjustment. - Other local anesthetics: cumulative lidocaine dose should not exceed safety limits. - Caffeine or sympathomimetic agents: may augment epinephrine’s systemic effects.